EC Number |
Inhibitors |
Structure |
---|
1.14.20.13 | (1R,2R,4S,5S,7s)-7-{[(2S)-3-hydroxy-2-phenylpropanoyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane |
slight inhibition by the substrate analogue |
|
1.14.20.13 | 1-methylpiperidin-4-yl 2-phenylacetate |
- |
|
1.14.20.13 | 3,4-dihydroxybenzoate |
competitive inhibitor with respect to 2-oxoglutarate |
|
1.14.20.13 | 6,7-Dehydrohyoscyamine |
- |
|
1.14.20.13 | 8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-(4-(dimethylamino)phenyl)acetate |
- |
|
1.14.20.13 | 8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-phenylpropanoate |
- |
|
1.14.20.13 | 8-methyl-8-azabicyclo[3.2.1]octan-3-yl benzoate |
- |
|
1.14.20.13 | 8-oxabicyclo[3.2.1]octan-3-yl 2-phenylacetate |
- |
|
1.14.20.13 | Ca2+ |
5 mM, 100% inhibition |
|
1.14.20.13 | Cd2+ |
0.4 mM, 100% inhibition |
|